A cluster randomized controlled trial of educational intervention by a community pharmacist to recommend ophthalmology visits for patients with diabetes mellitus

A cluster randomized controlled trial of educational intervention by a community pharmacist to recommend ophthalmology visits for patients with diabetes mellitus - NANOHANA study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000049274

Enrollment

300

Registered

2022-11-01

Start date

2023-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus

Interventions

Interventions: Provide a 30-minute online training session to community pharmacists in pharmacies assigned to intervention groups. The trained pharmacists will give recommendations of ophthalmology vi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients who have been diagnosed with diabetes mellitus more than six months prior. 2)Patients who have been prescribed at least one medication for diabetes mellitus (injection and/or oral medicine). 3)Patients with no ophthalmology visits for diabetic retinopathy for at least 1 year prior. 4)Patients who have given consent.

Exclusion criteria

Exclusion criteria: 1)Patients who have vision loss in both eyes. 2)Patients who do not have the ability to give consent or those who were absent at the time of consent.

Design outcomes

Primary

Measure	Time frame
Incidence of new visits to ophthalmology for diabetic retinopathy screening within six months.	—

Countries

Japan

Contacts

Public ContactAi Ogawa

Total Medical Service Co., Ltd. Operations Division

ai.ogawa.tms@msnw.co.jp+81-92-962-9200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026